Novel compound inhibits SARS-CoV-2 replication by binding a genome target - News-Medical.Net

Researchers assessed the biodistribution and safety of SBCoV202, a novel antiviral agent based on antisense technology that can specifically and effectively bind to the SARS-CoV-2 genome target to inhibit SARS-CoV-2 replication.

In a recent study posted to the bioRxiv* preprint server, researchers assessed the biodistribution and safety of SBCoV202, a novel antiviral agent based on antisense technology that can specifically … [+5960 chars]

full article...